A randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of new, highly selective a1A-adrenoceptor antagonist Silodosin in Korean patients with benign prostatic hyperplasia

Lee D H1, Song J M2, Kim C3, Lee H M4, Kim H J5, Kim D Y6, Lee G7, Ko W J8

Abstract Category

Benign Prostatic Hyperplasia (BPH)

Abstract 290
Non-Discussion Posters
Scientific Non Discussion Poster Session 32
1. Department of Urology, School of Medicine, Ewha Womans University, 2. Departments of Urology, Yonsei University Wonju College of Medicine, 3. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 4. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 5. Department of Urology, Chonbuk National University Medical School, 6. Departments of Urology, Daegu Catholic University College of Medicine, 7. Department of Urology, Dankook University College of Medicine, 8. Department of Urology, National Health Insurance Corporation Ilsan Hospital